Glenmark Pharmaceuticals

The drug is already being marketed in the EU, the US, and Australia.

Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver…

Earlier this year, Glenmark also launched Sitagliptin (Sitazit) and its FDCs, followed by Lobeglitazone (LOBG) and FDCs of Teneligliptin including…

According to the company, RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal…

According to the company, RYALTRIS is the only fixed-dose combination therapy that provides relief for the symptoms of SAR, both…